Recent FDA Product Recalls and Notices Recall of Injectable Methotrexate, Risk of Birth Defects with Paxil, Recall of Stainless Steel Greenfield Vena Cava Filters Manufactured Before 3-10-04, and Serious and Life-Threatening Cardiopulmonary Events associated with the Administration of NeutroSpec, Technetium 99m Tc Fanolesomab

Username:....................

Password:....................

Policy Library
Click here for
18,000 policy &
form templates

Home ť Browse All Libraries ť Food and Drug Administration ť Recent FDA Product Recalls and Notices Recall of Injectable Methotrexate Risk of Birth Defects with Paxil Recall of Stainless Steel Greenfield Vena Cava Filters Manufactured Before 3 10 04 and Serious and Life Threatening Cardiopulmonary Events associated with the Administration of NeutroSpec Technetium 99m Tc Fanolesomab

Subject:

Recent FDA Product Recalls and Notices Recall of Injectable Methotrexate, Risk of Birth Defects with Paxil, Recall of Stainless Steel Greenfield Vena Cava Filters Manufactured Before 3-10-04, and Serious and Life-Threatening Cardiopulmonary Events associated with the Administration of NeutroSpec, Technetium 99m Tc Fanolesomab

Category:

Food and Drug Administration (FDA)

Published:

Wed, 14 Dec 2005 - 10:00 am

Bedford Labs Initiates Nationwide Recall of Injectable Methotrexate On December 8, 2005 Bedford Laboratories, a division of Ben Venue Laboratories, Inc., Bedford, Ohio, announced that it is voluntarily recalling one lot of Methotrexate for Injection (preservative free), USP 1 gram per vial (NDC 55390-143-01), Lot# 859142, exp 09/07. The manufacturer of the Methotrexate USP active drug substance, ADS, informed Bedford Laboratories that the...

The full article is available to StayAlert subscribers. Click here for a free trial subscription.

REFERENCES:

Policies / Forms / Additional Resources:

Policies, forms and resources are available to subscribers only. Get free trial subscription.

StayAlert! provides immediate notification of regulatory body legislation impacting the healthcare industry, helping you to meet regulatory compliance. Subscribers are notified of any new or revised regulations, provided with a summary of the regulation, followed by an implementation action plan and/or policy. Designed as an e-mail "push" method for rapid customer notification of healthcare compliance issues, paired with interpretative analysis and practical application, the StayAlert!^® Virtual Compliance Administrator™ saves you time and money.

The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up.